VALEANT PHARMACEUTICALS v. MYLAN PHARMACEUTICALS , No. 19-2402 (Fed. Cir. 2020)

Annotate this Case

This opinion or order relates to an opinion or order originally issued on November 5, 2020.

Download PDF

Case: 19-2402 Document: 74 Page: 1 Filed: 11/06/2020 United States Court of Appeals for the Federal Circuit ______________________ November 6, 2020 ERRATA ______________________ Appeal No. 2019-2402 VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN INC., Defendants-Appellees Decided: November 5, 2020 Precedential Opinion ______________________ Please make the following change: On page 6, line 10, change “Mylan” to —Valeant—.

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.